Main Content
All the Rest
IBCC chapter & cast: Post-MI complications
Myocardial infarction patients are complex. Unfortunately, this complexity can grow over time. Delayed deterioration in the patient recovering from MI may result from a host of different problems (e.g. medication effect, procedural complications, or merely the natural history of the disease). This chapter explores some problems that we should be on the lookout for in […]
PulmCrit- Metoprolol causes harm in COPD?? Déjà vu all over again
We’ve been all over the road with beta-blockers and COPD. For a long time, there was a belief that beta-blockers were contraindicated in COPD. Eventually that concept fell out of favor. Subsequently, some correlative data suggested that beta-blockers might be beneficial in COPD. This led to the current BLOCK-COPD trial which (spoiler alert) shows that […]
Tox and Hound – Color Me Blue
by Christine Murphy Alternative Uses for Methylene Blue I like finding alternative uses for existing antidotes. Antidote research is very limited – let’s be honest, there isn’t a huge market out there for most antidotes. So, anytime an existing antidote’s use can be expanded to other indications, I think that is a win. Methylene blue […]